Russia to attract Middle East drugmakers to domestic pharma market

Amid the ever-declining drug imports from Western countries, Russia is ready to increase supplies of drugs from so-called “friendly” countries, The Pharma Letter’s local correspondent report.

These are primarily countries of the Middle East region, which drugmakers in recent months have announced their plans for the increase of supplies to Russia.

One of such is the Iranian biosimilars company CinnaGen, which is currently conducting clinical trials of a drug for type 2 diabetes in Russia. Recently, such drugs have become in short supply in the Russian market, which contributes to the growth of their local demand.